Public Accounts Committee
Oral evidence: NHS Accident and Emergency departments, HC 764
Monday 2 November 2026
Ordered by the House of Commons to be published on 2 November 2026.
Members present: Sir Geoffrey Clifton-Brown (Chair); Mr Clive Betts; Anna Dixon; Sarah Green; Rupert Lowe; Tristan Osborne; Matt Turmaine.
Gareth Davies, Comptroller and Auditor General, National Audit Office, Andy Morrison, Director, National Audit Office, and George Osborne, Alternate Treasury Officer of Accounts.
Questions 1-94
Witnesses
I: Samantha Jones OBE, Permanent Secretary, Department of Health & Social Care, Sir Jim Mackey, Chief Executive Officer, NHS England, Dr Emma Rowland, Executive Director, performance and delivery NHS England; Chief Operating Officer of Homerton Healthcare Foundation Trust, and Professor Tim Briggs, Consultant Orthopaedic Surgeon and Chair of the ‘Getting It Right First Time’ programme, NHS England.
Report by the Comptroller and Auditor General
Managing the flow of patients through hospital from A&E (HC 588)
Witnesses: Samantha Jones OBE, Sir Jim Mackey, Dr Emma Rowland and Professor Tim Briggs.
Chair: Welcome to the Public Accounts Committee on Monday 2 November 2026. Since 2014, accident and emergency departments at the national level have failed to meet their constitutional target: that 95% of patients be discharged, transferred or admitted within four hours of arriving at A&E. In addition, the proportion of patients waiting in A&E for more than 12 hours has tripled, from about 3% before covid-19 to about 10% in 2025-26. In May 2026, during any 24-hour period, almost 3,000 people were waiting in corridors.
Not only have wait times risen, but costs have, too. The cost per patient in A&E has increased by a third, from £211 in 2018-19 to £280 in ’24-25. Overall spending in A&E has increased from £4.3 billion in 2018-19 to £6.6 billion in 2024-25. That represents a wholly unacceptable level of care, with the increase in long waits and the rise of corridor care significantly impacting patient safety. Analysis by the Office for National Statistics estimates that patients who wait in A&E for 12 or more hours are twice as likely to die as patients who wait for two hours.
Today, we will therefore challenge NHS England and the DHSC on A&E waiting times, patient experience in hospital, and rising costs and flow within hospitals. We have a very senior team here with us. Will each of you please introduce yourselves?
Samantha Jones: Good afternoon. I am Samantha Jones, permanent secretary at the Department of Health and Social Care.
Sir Jim Mackey: I am Jim Mackey, chief exec of NHS England.
Dr Rowland: I am Dr Emma Rowland. I am an A&E consultant and the NHSE exec for performance and delivery.
Professor Briggs: I am Tim Briggs, a clinician and surgeon, the national director for clinical improvement and elective and UEC recovery, and chair of the GIRFT programme.
Chair: Thank you all very much. Dr Rowland and Professor Briggs, I think this is your first time at the Committee. You are very welcome; I hope that even if you do not enjoy it, it will at least be enlightening for you and us. I hope you have been warned about Anna’s top-of-the-session question. [Interruption.] Maybe not. You will have to do your best to answer us, please.
Q1 Anna Dixon: Thank you, Chair. I should first declare a potential conflict of interest, having previously worked at the Department of Health.
We had you in previously, at the time that the reorganisation of the NHS England was announced. The Health Bill is currently passing through Parliament, to provide for the legislative abolition of NHS England. When it was debated in the House of Lords, there was considerable discussion about the transition plan and the costs of transition. I wonder if you have any update for the Public Accounts Committee as to your estimates of the cost of the reorganisation associated with the abolition of NHS England.
Samantha Jones: I will come back to the Committee to confirm the latest, if that is okay; I do not want to give you something on the hoof. What I can confirm is that, as the Secretary of State said at the Dispatch Box, we remain totally committed to the abolition of NHS England and the creation of the new Department. Further information will be coming in due course.
Q2 Anna Dixon: I think you will be back with us for a session on ICB reorganisation, so I will be grateful if you can make sure that we have received any information ahead of that hearing, so we can include a further question.
Can you clarify—this may be one for you, Sir Jim—something reported in the news about the possibility of needing to create a separate arm’s length body, because it is not possible to absorb all staff, particularly those on senior salaries, into the Department of Health and put them on civil service pay grades? Could you provide clarity on that?
Sir Jim Mackey: As Sam said, the Secretary of State will be making some more announcements on this in the very near future. That has been subject to debate very recently. One of the key points is not just on terms and conditions, but about alignment with the devo principle and philosophy. So it is not fixed yet; it will be communicated very soon.
Samantha Jones: Just to build on that from Jim, it is obviously hugely important—we have discussed this before—that we discuss anything with our staff. That is our commitment: to make sure that we communicate appropriately as much as we can. But yes, as Jim said—
Anna Dixon: So for now they are unconfirmed reports in the media; they have not come directly from you. Okay.
Chair: That is very helpful. Just for the record, my Clerk did say that you had been warned of that question, I think.
Samantha Jones: I apologise.
Q3 Chair: Thank you, anyway, for those answers. We look forward to hearing further on Anna’s inquiries.
Before I bring Rupert in, I would like to raise an important issue that was raised both in the NAO Report and by the Royal College of Emergency Medicine. I think you have had sight of this evidence, because it was published a little while ago. On page 1 of RCEM’s report, it says: “There were” around 16,000 “excess deaths” in England “associated with long waits” in emergency departments. The NAO, in paragraph 1.9 on page 19 of its Report, delves down into this a little further. It says: “Twelve-hour waits are associated with higher mortality.” This is clearly a very difficult and sad situation. What do you intend to do to reduce that?
Samantha Jones: If you are comfortable with this, Chair, I will ask Emma to answer.
Dr Rowland: I want to acknowledge initially that behind every one of those numbers is a patient and a family. I think we are all in complete agreement that that is completely unacceptable; that is not what we want to see or deliver, so our focus is absolutely on eliminating and abolishing all those long waits.
It is a complex system. The predominant causation of patients residing in corridors or any other treatment escalation space, as they are called—places that are not suitable for clinical care—is essentially flow: problems with flow. All those patients who are currently in a corridor should be in a hospital bed. That is the bottom line, so the question is why they cannot get to those hospital beds in a timely and safe fashion. The cause of that is the delay all the way through the system, but particularly at what we call the back door—the back of the hospital. It is about that flow through the hospital system and encouraging a timely discharge, timely hospital processes and timely exit from A&E, but also timely system processes around the hospital to support that.
Q4 Chair: So you do accept the causation—that long waits do lead to excess deaths—and that is the main reason why we need to do something about those long waits.
Dr Rowland: There is absolutely no doubt that long waits, particularly in A&E, cause harm. We are in agreement with that. Likewise, long waits increase patients’ length of stay. And likewise, long and inappropriate stays in hospital cause harm.
Chair: Thank you: that is a very clear answer.
Sir Jim Mackey: Can I add to that? First, we are all in agreement that this is a good Report. It is a very good, balanced view. It emphasises that we have to look at the whole system rather than parts of the system. Hopefully this afternoon we will explain what we are doing about all that. We have had some really useful challenge from the new ministerial team, especially on discharge and the impact of discharge, and rebalancing the plan. But probably what we will mainly try to convey is that this is all very complicated, especially in the context of all the things we have had to do in the last year on financial turnaround, improvement in various settings and so on. This year, the main thing that set us off course has been quite a strange increase in demand from the early part of the year, which we are still struggling with. But at no point will we be disagreeing with the content, balance or tone of the Report. I think it is a very good Report and very helpful for the service.
Chair: We agree that it is a very helpful Report. We will be delving into some of the specific issues that you have been talking about in the course of this hearing. To start us off on that, could we please turn to Rupert Lowe?
Q5 Rupert Lowe: I echo your comment. The NAO’s production of a great Report, as usual, has helped us to understand this better. I come across this quite a lot in my constituency of Great Yarmouth with the James Paget hospital, where we do have issues with A&E, so I am quite aware that it is a major problem across the country.
My first question is this. In the NHS constitution, you promise that 95% of patients will be admitted, transferred or discharged within four hours in type 1 A&E. You last met that target in 2013-14. It appears that you now have an interim target of 85%, but not until 2028-29. In which year will you meet the 95% that is in your constitution?
Sir Jim Mackey: You have rightly pointed out that it has been a long time since the NHS delivered that standard. The way I remember it is that in the run-in to covid, we had had a long period of steady decline. Then we had the covid event, and we have struggled since then to get back to normal levels. The Report acknowledges some progress since then, but as I described at the beginning, given all the other competing challenges—the overall resource position, and so on—we have tried throughout to set targets and objectives for the service that are stretching, but not so stretching that we are beyond reaching and everybody gives up.
When the last plan was published, because there was an uncertain medium-term financial position, we did not commit to a time to deliver on the standard overall. That is what we are aiming for every day, but from where we are now, it is not going to be in the next couple of years. It is going to be a longer timeframe than that.
Q6 Rupert Lowe: Have you got a date, Jim?
Sir Jim Mackey: No, we haven’t. We are just about to go into further discussions about planning and objectives for next year, so we have not set a date for complete delivery of that overall standard. Part of that is about the demand growth we have had this year, which has knocked us off course a little bit.
Q7 Rupert Lowe: Should it be in your constitution? Is it just words in the constitution? If you cannot give us a date, you cannot really be taken seriously on delivering it.
Sir Jim Mackey: It is a constitutional standard, and I would like every NHS organisation to deliver this standard every day, but it is just realistically not something we can plot a path to from where we are now.
Q8 Rupert Lowe: It concerned me when I read your own analysis. The NAO says that we need 115,000 to 120,000 beds, and I think you have around 103,000. Is that right?
Sir Jim Mackey indicated assent.
Q9 Rupert Lowe: The NAO Report says that you have not actually costed the gap. If you have not costed the gap, you really cannot be that serious about delivering on that 95% target, can you?
Sir Jim Mackey: We know what the cost of a ward and the cost of those beds are. What we have not got is a realistic prospect of being able to secure that overall level of resource. We are all trying hard to shift patterns of care, so that people currently being treated in beds are treated nearer the home, through SDECS and UTCs, in neighbourhoods and so on. All those things are currently being considered, but if we said that the only plan was to open 15,000 extra beds, we could not afford it and we could not staff it. There is an imperative as to how quickly we can change the pattern of care. One thing that does not come through strongly in the Report is the implementation of same-day emergency care across the service, which has materially reduced our reliance on beds in the last few years. You are right that if you look at where we are now—performing as we are now, and with the clinical systems we have now—we will need a lot more beds, but we are trying our very hardest to find alternatives to that through shifting the model of care.
Q10 Rupert Lowe: As the Chairman says, that statistic about people being twice as likely to die if they are waiting for 12 hours rather than for two hours is pretty shocking. It strikes me that it is quite important to try to meet that target. With regard to corridor care, which is a major problem still, are you now collecting data each month on how many people are in corridors waiting to be treated?
Sir Jim Mackey: We are, and we have been since the spring. I asked Tim last year to get involved in this.
Professor Briggs: I was asked to get involved in trying to resolve this issue of corridor care in September last year, bringing the GIRFT methodology and the clinical leads to bear to try to make a big difference. We have gone live now with a new definition of 45 minutes in an undesignated space. That is being measured. There is some discrepancy between what we say is corridor care and what RCEM says. We think that the answer is somewhere in the middle; we are probably under-reporting at the moment.
The critical thing for me is the risk of the patients they have in the corridor. The corridor care piece, where people are in the corridor, could occur at any point along the pathway; you do not have to be admitted to end up in the corridor. As we tackle that, it is really important to tackle the areas where there is the greatest risk. If you look at the patients in the corridor, 60% are over the age of 65, and that is the real risk to us: these patients who are frail with multiple comorbidities. We have to try to manage them first and get them out of the corridor as quickly as we can.
In the last year, we have worked very hard with 45 trusts. Of them, 21 are in what we call a Further Faster cohort, and they were just about managing. We also work with 24 tier 1 trusts that were not managing at all. We brought in our clinical leads and got the data, and then we went in to help. When you look at corridor care, the issue is the whole pathway. Often, when we went to these trusts, they were silo working. Everyone was trying to work hard and do a good day’s work, but we found that it was silo working, and we needed everybody to own a problem—both all the clinicians and the management teams.
We did a lot of work with the 21 trusts. We improved on the four hours and ambulance handovers and reduced the 12-hour wait and therefore corridor care. In the tier 1 trusts, where the back end was really the problem, we reduced 12-hour breaches by almost 12%, so we knew that our methodology would work. We then worked with nine providers and six trusts to focus on corridor care, and we were able to reduce that by 50% to 60%, so we know that our methodology is right.
We have been working with 40 trusts this year. We have just agreed with Emma and the regional COOs on the 40 trusts that we will use all our efforts on this winter. I hope that we can make a significant impact, but it is hard yards. It will be at trust level, working with the trusts to change cultures and behaviours and get the whole team working as one, from the front door right through to discharge. But we are on our way, and I think that we are seeing a change in behaviours that will make a difference.
Q11 Rupert Lowe: How many were treated in corridors in September, for instance?
Professor Briggs: It was 3,300 a day and about 99,000 a month.
Rupert Lowe: And that is not a winter month.
Professor Briggs: No.
Q12 Rupert Lowe: Are you going to publish a plan on how you will deal with it? When I am running something, I always think that a plan written down with an actual structured approach is better than words around a committee. Will you have a plan published? I really think that this is quite serious.
Sir Jim Mackey: In the last year, we have used the model ED and the model discharge—some of that is referred to in the Report. When we have a bit more reliable data over a longer period of time, we would expect Tim and colleagues to produce a model approach to eliminating corridor care.
There is absolutely a harm issue, but we should not lose sight of the dignity issue. A patient could wait a long time and not suffer harm but still have a horrible loss of dignity, so we should acknowledge that. We are all very focused on that, and colleagues are as well.
Rupert Lowe: As somebody over 65, it worries me slightly that I might find myself in a corridor one day.
Samantha Jones: Just to confirm, the Secretary of State and the ministerial team, as Jim said, have been very clear that there is no tolerance at all for corridor care. The challenge from the ministerial team and the serving Secretary of State is for a plan to come back on eradicating it that details the time period and who is doing what. In terms of the answer to your question, it is very clear.
Q13 Rupert Lowe: I have two other quick questions. One thing that also concerned me was that there does not appear to be a correlation between how much money you spend and how successful you are. It seems that you have hurled a lot of money at this issue and it has not got better. You mentioned some things you are intending to do. Are you now aware of a better approach than just hurling money at it? You have had a chance to look at it. How will you solve it?
Sir Jim Mackey: The answer, as the Report says, is to look at the whole system. It is factually correct that, post covid, there were two or three years of significant investment in the workforce in this area and generally across the NHS. That is partly what we have been dealing with in the last year; just trying to address that. Last year was the first year in 12 years that we did not have a workforce growth and the first year in 11 years that we did not have to call on the Treasury reserves. There is a correction going on there.
Clinical colleagues should speak up, but I do not think the answer is putting more money into the ED. We have definitely got discharge problems and social care investment problems, and we want to do more in neighbourhoods, so it is more about how we address the whole thing. Again, what this Report and our performance data prove is that all these things are connected and if we squeeze one part of the balloon without changing other parts, it is just going to pop out somewhere else. I think you can see that day to day, especially in some of the places Tim and Emma work regularly, where part of the system is being fixed but not the whole system. That is really what we have to try and do in the next couple of years.
Professor Briggs: Can I add to that? From a clinical perspective, last week I visited 22 PCNs across five regions as part of a programme we have been doing for two years. What the PCNs—
Samantha Jones: The primary care networks.
Professor Briggs: Sorry, the primary care networks. We met all the GPs and found that, since we have given them the headspace to look at their population and use neighbourhood and community services, they have been able to look at the most vulnerable people. They have looked at people with multiple comorbidities—frailty, mental health issues—and those patients who, if I may say, were frequent attenders either in the ED or the GP surgery. Universally, across the 22 PCNs in the five regions, there was a 23% drop in ED referrals as a consequence of that.
If you add to that the care homes, there are care homes that have frequent referrals to the ED, while others do not. Again, working with GPs and providers, they are now aware of the top three care homes that have the highest number of referrals, so they can work with them in a clinical way to make sure the patients are managed in the right place, are getting the right care that they need and are using community services.
Secondly, on ambulances, we are working with all 11 ambulance trusts—I have included Wales in that because in the west of England, the Countess of Chester hospital and places like that have a lot of patients coming over from Powys. Again, we have asked them to do five things this year to standardise, which they are working very hard to do. They include call before convey, hear and treat, making sure that we stream patients and that we have a maximum handover time of 45 minutes—although we want it less than that—and managing patients who do not need to come to the ED that evening but can come tomorrow and managing how we keep them safe in the community.
All of that feeds into the front end of the pathway. As I have said, if we are going to get this right, we have to resolve the whole pathway. I think we are making progress there and, as Emma said, we are working at the back end of the whole pathway within the acute trusts to try and make sure that we have a better winter in terms of flow.
Q14 Rupert Lowe: That is exemplified, is it not, by this £2 billion cost in less than a year as a result of people being in hospital for longer than they need to be?
Professor Briggs: Yes.
Q15 Rupert Lowe: My last question on performance and the timing involves senior executives and their pay. I came across the TaxPayers’ Alliance rich list for the NHS in 2026. I have to say, Jim, that you came out pretty high up; it looks like you were making out like Dick Turpin at the Newcastle NHS trust.
I looked up the best and worst-performing trusts by A&E waiting times: Humber teaching trust came out top and East Cheshire trust came out bottom. For me as a businessman, the key here is that there does not appear to be any correlation between the pay and rations of people who do very well and the pay and rations of people who do very badly. Indeed, in a year, the pay of a person in East Cheshire went from £172,000 to £377,500, even though it remained the worst-performing trust for A&E waiting times for the second consecutive year.
Is there now a correlation? You mentioned in your report that there is an intention to link performance to pay, which must be one of the things you probably need to do to get this problem sorted out. No.1, has that happened? And No.2, how many people have underperformed and therefore been penalised since you introduced that rule?
Sir Jim Mackey: There is a link to the oversight framework. Our way of looking in the round at organisations is to segment them from high performer right through to the lowest performer in the lowest categories of performance. Other than where there is a need to change a team and encourage people to come in to run the organisation—some of the organisations you mentioned have had lots of turnover over the years—it would generally be the case that if you were in those lower categories you could not receive a pay rise. That was the intention. It is, as I say, complicated if you have had a lot of churn and you have to pay the market rates to encourage a chief executive and executive team to join an organisation in trouble.
Q16 Rupert Lowe: Has anyone been penalised yet for lack of performance?
Sir Jim Mackey: There has been no pay award paid generally this year, for anybody.
Q17 Rupert Lowe: That is everybody, but what about the underperformers?
Sir Jim Mackey: It is the intention that, for the lowest segments, pay awards will be withheld.
Q18 Rupert Lowe: Wasn’t there a plan to penalise them and actually reduce their salaries? I thought I read that in the Report.
Sir Jim Mackey: The action has always been—there was a policy agreed last year— that if you were in the lower segments, you would not earn the annual pay rise. You could not just automatically reduce anybody’s salary, but you would withhold pay awards until performance was at an acceptable level. That has been applied with, as I say, one exception: if you have an organisation where the team or board has changed and you need to encourage people to come in, you have to pay appropriate market rates for them to go into that organisation.
Rupert Lowe: From the Committee’s point of view, that is—
Chair: Rupert, we must move on, because other Members have a lot they want to ask. I will bring Matt in in a second, but I think my able deputy had a point about Professor Tim’s point about GPs.
Q19 Mr Betts: Professor Briggs, I spoke on Friday, fortuitously, to a GP in my constituency, Tom Holdsworth, who is chair of the Townships 1 PCN, which is in one of the national pilots on frailty and what could be done to improve it. I understand you have been to see the project, and I understand—they referred to this—that there has been a net saving of about £600,000 per annum as a result of the work done to improve frailty among the patients. That is net. The initial cost is, I think, £350,000, and the saving is nearly £1 million. I understand that the ICB is now saying that they cannot find the money to continue the project next year. Come on, what’s going on? We have a project that is actually delivering savings, but the initial funding to deliver those savings is now beyond the ICB at local level.
Professor Briggs: I was there on Friday, and all the PCNs in Sheffield and Rotherham have done extremely well in terms of what we are talking about—reducing referrals for those patients with complex needs. In addition, two of the trusts, Barnsley and Rotherham, are really good, in that they have very low numbers when it comes to 12 hours in corridor care. They are doing extremely well. To be fair, we had a very good discussion about their impact. When you bring all the 22 PCNs together and look at the data, it is very powerful about how we are going to solve this problem.
There was a discussion with the ICBs, and I have to say that the ICBs were very open and very fair about taking this away, looking at the evidence and deciding whether they were going to continue it. The message I got from the ICB in Sheffield was that they were going to do all they could to make sure it continued. We highlighted the fact that the clinical staff had gone from just about managing to being able to see real light at the end of the tunnel. We were really keen that this continued, so we have asked them and they have been given money to show the evidence of what they have done. We are going to produce the evidence across the 22 PCNs. I think the evidence for its continuing is very powerful.
Q20 Mr Betts: It is very powerful. The ICB’s reply has apparently been that they can probably find the money for three months and then the project comes to an end.
Sir Jim Mackey: If you could encourage the person who told you that to get in touch with me and provide the information, I will pick it up with the ICB.
Q21 Mr Betts: It was Dr Holdsworth, who chairs the PCN. They have been told that NHS England is not happy, and has told the ICB to try and find money for six months. You know, this is an example of the bureaucracy of the NHS being detached from the clinical experience of GPs.
Sir Jim Mackey: Generally, on a weekly basis, I get two or three of these. Often, there is something behind it about the ICB wanting a bit longer on the data to be able to prove its case. Occasionally, there is a complete misunderstanding of how the financial flows work, but if I can get the facts, I will pick it up with the ICB.
Chair: Clive, you have an open invitation there to email Sir Jim with full details.
Mr Betts: Okay. Professor Briggs, you will no doubt continue your interest in this as well.
Q22 Matt Turmaine: I would like to go back to corridor care for a moment. West Herts teaching hospitals trust, in my patch, runs Watford general hospital, which is in desperate need of rebuilding as part of the NHP, but I am sure you know that. Nevertheless, the team on the ground at that hospital are fantastic, and they have eradicated corridor care. I know a couple of Secretaries of State have been to see them and talk about it. When you have that best practice, what are you doing to share it across the system?
Dr Rowland: Several of us have also been to visit West Herts, and they are a fantastic team—I would second that. I took my team from Homerton—we are a high-performing trust—to go and learn, for exactly that reason. I know that, since then, they have done several visits. There are lots of good ingredients there, and we absolutely have to learn.
The question is, then, what do we share, and how do we share it across the patch from a delivery perspective? There are a couple of things for me. No. 1 is exec engagement. It is very clear, certainly from their chief nurse, how engaged she is. I am sure many of us have met her; she is fantastic. She got down and spent time in A&E, understanding what the challenges and barriers are, and then made a commitment at exec level that it was going to be no more—that it was a red line for them.
The question is, once you have done that, how do you unpick it? As I say, there is lots that they have done there. They have focused, exactly as my colleagues have said, from the front door all the way to the back door. One of the good front-door examples that they have done is what is called call before convey. What they are trying to do, particularly if patients are frail, is bring together a combination of the ambulance team and the hospital team to say, “Is there an alternative in their patch that could be offered to them?” Certainly, we are learning across how we lift and shift some of that.
Secondly, in A&E itself, how do you take the model ED that we have done? We have learned from them. They have been around the table for several of our models, particularly model ED and model discharge. How do we take that good front-door practice of the streaming, assessment and flow through A&E?
Thirdly, on the hospital part, particularly around discharge, they have come together with their providers. Particularly for their frail and most vulnerable population, how do you ensure a timely discharge? They have really focused there. On the frailty, we are also trying to take three examples, of which West Herts is one, and we have put people together with other good providers and said, “How do we replicate this?” We are bringing together very specific providers to provide that peer support at a local level. This is probably more for Professor Briggs: how do we take it as something overarching, and how do we get it right first time? That is exactly what GIRFT is designed to do.
Professor Briggs: We now know what works. For me, the West Herts thing is all about leadership. The CEO, the CMO—chief medical officer—and the chief nursing officer have driven that trust into the place it is today. If they can do it, we can do it everywhere.
We have tried to set standards with what we call the GIRFT clinical operational standards, setting the time when patients come in, and when they are seen and then flow through the hospital. We have produced documents about reducing length of stay, because we now know how to do that, and about how we can improve, discharge and use the discharge lounge more appropriately, so you can get 10 patients there before 10.
Then, we have a UEC improvement guide, which builds on trusts such as West Herts and others that are doing things really well. Now we have got those, we have got the teams to go out there with the trusts that we are helping, and we want them to adopt and embed all these processes. That is what is going to be different this winter, and that is what we want them to do. We do not really want it to be optional, because we do not want to lose the learning of places like West Herts and others—Maidstone and Tunbridge Wells, and others in Northumbria and Newcastle, where Jim is, and so on. There is some really good work out there. You just need to scale that up and then help, and that is what we try to do—to help trusts, clinicians and operational teams embed it. That is how we are going to improve the flow of patients.
Sir Jim Mackey: Just to add to that, with the help of the Corridor Care Coalition, we have a couple of events. I think a nursing colleague at West Herts gave a very powerful presentation at the first event. Because of their physical constraints, we have found it most helpful if people go and see them, because it is the sort of the place where, if you see that they have solved it, it must be solvable everywhere, because they are working with really terrible physical constraints. It is an absolute leadership commitment throughout the organisation. What struck me in the event was the power of the nursing voice on standards, compassion, doing the right thing for patients and so on. Some took that away and it has helped their journey; others are still really struggling with it and have not quite got off the ground yet.
Samantha Jones: Just to add, I know the trust very well from a very long time ago, and the other bit that the leadership have done is work very well with the local system and local partners. They are a very good example of practical neighbourhood health and care in practice, which they have been doing alongside the internal flow and leadership elements.
Q23 Matt Turmaine: That is great; thank you very much for that. Tim, you were saying that this winter you are looking to scale it up and roll it out—although perhaps not across everywhere in that timeframe.
Professor Briggs: We are going to work with 40 trusts this winter that we have agreed with the regional COOs and with Emma. We will deploy the team with these documents and what have you, plus the knowledge. There is the challenge but also the support to enable that whole pathway to be entered into, along with the work that we are doing with the ambulances and primary care.
Samantha Jones: The Secretary of State recently announced the investment in urgent treatment centres and the capital, with a further 25 new or expanded urgent care sites to be opening before winter. It is not necessarily about the model of care, but it is around supporting in terms of capacity constraints as well.
Chair: Thank you very much, Matt, for drawing our attention to what sounds like a very successful operation in Hertfordshire.
Q24 Sarah Green: Sir Jim, why are so many people still waiting 24 hours or more for care when NHS England’s own guidelines state it is a red line for safety?
Sir Jim Mackey: It is mainly because of the complexity of the system and lots of things needing to be fixed at the same or similar times. The organisations with the most stubborn problems generally have more of a discharge and bed capacity problem, which is a really stubborn thing. It is a complicated thing to unblock. It involves partners, is very expensive and so on. If we could solve it tomorrow, we would solve it tomorrow, but we have to do it at a pace that we can afford with partners and while making sure that every part of the system works together.
Q25 Sarah Green: Your own documents refer to zero tolerance towards it. What does that look like in practice?
Sir Jim Mackey: It is a version of what we saw in West Herts: a leadership commitment to basically saying, “We are going to do absolutely everything we can within our power to eradicate this.” In places where it has been possible—probably where there has been much less of a discharge or social care interface problem—it has been more down to the leadership effort and everybody pulling together to eradicate it: clinical, operational and administrative. Tim has described a process whereby it does not work unless there is a leadership commitment that is that focused and driven to try and eradicate it.
Q26 Sarah Green: Does that come back to your point earlier about culture?
Professor Briggs: Let me give you two examples where we have gone to help a trust that had a real problem. BHRUT is in east London. We were asked to go there because they had 55 patients in the corridor and were struggling to move those patients. We got a commitment from the leadership—from the medical director, the chief nurse and the CEO—that we were going to say, “This is just not acceptable, and we are going to do something very different.” Over three months, we were able to clear the corridor. There has been a little slippage back since that time, but on the whole, they are doing very much better. It just shows what can be achieved.
The other example I would give you is—
Q27 Sarah Green: May I interrupt you? What specifically changed?
Professor Briggs: It was the agreement by all that this was unacceptable and that we had to do something really different. When you went to the corridor, there were patients over 65 in unacceptable places. Everybody agreed that this was no longer acceptable. The triumvirate—the chief executive, chief medical officer and chief nurse—said, “Right, we are going to do this differently.” We were able to support them with implementing the clinical operational standards regarding how we are going to get discharges out and what we are going to do at the front door. We were able to make a really big difference. What was amazing was how the morale in the hospital improved so much afterwards. They could now see that there was a way out of this.
I will give one other example, which is in East Kent at William Harvey hospital. They had patients—I think this made the news—in the Costa Coffee corridor, which was totally unacceptable. They realised that, so they asked us to go and help. Again, it was exactly the same scenario: it was unacceptable, the leadership gave them the tools, and there was also the support from my team to help them—and they cleared the corridor. That just shows how working together and the work we are doing in NHSE can make a big difference.
Q28 Sarah Green: Were you invited in by the teams, or were you sent to intervene?
Professor Briggs: It is a mixture, I have to say. In the early days, I think we were asked to go in, but now we are welcomed with open arms. In fact, I think we have more people asking for our help than we have capacity for at the moment, but we are hoping to reorganise the teams. But no, we have never been refused when we have offered help. Everybody has said, “Yes, please.”.
Q29 Sarah Green: Thank you for that. I will turn to the patient experience and ask the permanent secretary: what plans does the Department have to capture and utilise the patient feedback and experience to help improve the situation in A&E, and how are you using them?
Samantha Jones: If I may, I will ask Jim to start and then I will pick up after that.
Sir Jim Mackey: We have just appointed a new patient experience director, Jacob Lant, whose job is to bring a new approach to all of this. He will have a view when he has started—and he starts very soon, this week or next week—and give us a—
Q30 Sarah Green: Have you already appointed him?
Sir Jim Mackey: He just started this week, I think, and he was appointed a few months ago. His job is to try to shift us away from annual surveys into a world where we are much more actively measuring experience in a real-time way—some organisations around the NHS do that, but trying to do it systematically across the whole of the service. He will have a plan within a few months as to how we are going to go about that.
Samantha Jones: Just to build on that, for the creation of the new Department—as part of the transformation—the Secretary of State set a very clear challenge to ensure that the way Jacob puts things together has the patient’s voice at its heart, such as the decision around the abolition of Healthwatch to make sure that we truly are taking the patient voice. The information is being taken locally to make a difference. We have patient complaints that come through and are reviewing those from a departmental perspective, but the Secretary of State has charged us very clearly with giving Jacob—obviously, with more than a day to start—the job of how we best ensure that we have the patient, citizen and family voice at the centre of what the Department does on a daily basis. I suggest that we can come back with further details on that when he has been in post for more than a day.
Sarah Green: The Committee would welcome that.
Sir Jim Mackey: There is an example that started in Northumbria and continued after I left, which tried to connect patient and staff experience with length of wait as well. I can share that with you after this, if you want to see it. We would like to try to bring that kind of approach to this setting. That work found that patients were often more tolerant than you would expect them to be, as long as they were communicated with and could understand what was going on.
Q31 Sarah Green: That is interesting. So if they know where they are and what is happening, and if their expectations are being managed, it is different.
Sir Jim Mackey: Yes. But the impact on staff was higher than you would expect it to be as well, where they were feeling the burden of letting the patients down.
Q32 Sarah Green: I can see you nodding, Emma. Did you want to add something?
Dr Rowland: Just to add, from the day-to-day A&E perspective, that we know and can see hands down that if you communicate and are clear with the patients, they can see what is going on and understand the situation around them. As long as they know what is happening and see what is happening to them, they are relatively comfortable and assured. It is when they cannot see or understand what is going on, or they wait for extended periods of time with no information in that void, that we see most of our complaints. I have answered many, many complaints in my time and that is a hands-down standard thing.
Sarah Green: That is really helpful.
Samantha Jones: I would just add that none of us are complacent at all about the impact on individuals, as Jim said, from both a dignity and a harm perspective. I would not want any member of the Committee to feel that we are either complacent or not focused on it in terms of the things that need to be done. I think that the particular learning is making sure, as Jim said, of the whole-system approach—I am sure we will come on to social care a bit later, but I just want to finish—and there is no complacency at all from any of us about the impact on individuals and families.
Sarah Green: I am sure my colleagues will be keen to hear the detail once your colleague is established in role.
Q33 Chair: The president of the Royal College of Emergency Medicine, Dr Higginson, who I am sure you know well, did an interview for LBC that was headed: “A&E facing perfect storm ahead of winter—as leading medics warn only 3% prepared for severe pressures”. He says that the number of people admitted to A&E was nearly 45,000 in August, but in September it was 50,500. What preparations are you making to be able to cope with a severe outbreak of something like influenza on top of that quite distinct increase in summer demand?
Dr Rowland: As you rightly say, I know Dr Higginson very well, and he is right to say that we have had a really difficult summer. That is the first thing to say. Certainly, from an attendance perspective, in A&E it has been higher than anticipated and is being maintained: even from September to now it continues, so we know that demand at that front door is a problem. The good news, where I would suggest that some of the investment we have made and a lot of the work we have done at the front door is working for things like our same-day emergency care and our urgent treatment centres, is that that increase in attendance is not translating to an increase in admissions to hospital. That is a good thing to take out of some of the work that has been done.
That aside, because of the flow and the challenges we have already alluded to at the back door, it does mean that we have what is called less operational headroom going into winter, which is what he is rightly flagging. The capacity and the occupancy of the hospital at the moment is very high, and higher than we would like it to be going into winter.
For winter itself, we have done a lot of preparations. We have prepared earlier than usual. A lot has gone on. Bringing up some of the previous points on culture, we have gone for board assurance statements about how the trust, the integrated care boards and the regions are all assured by their plans and what that includes. For example, how do we look after our frailest population during winter? How do we ensure that primary care is there to meet people’s needs? How do we ensure that people are vaccinated? Particularly from the children’s perspective and our staff perspective—all the way through—how do we prevent the things we can prevent, particularly for things like influenza?
Then we come to preparing the hospitals, which is another way of looking at it. We are focusing heavily on discharge and have done since the beginning of September so that we can clear out, as safely as possible, some of our hospitals to recreate some of the headroom. Over December we have created some new data, looking at data and discharge delays, so that we can understand the challenges of what is going on and get some of those foundations right. We have published, as it said in the Report, not only the model ED—the acute care pathway—but the model discharge, so how we ensure that patients flow safely entirely through our hospitals. We are working incredibly tightly with social care particularly about how we can enable hospitals and social care to work closely together to ensure that we can improve that discharge process at the end. We are trying to create some of that additional headroom.
The third thing I would bring to the Committee’s attention is what I call the process, particularly from an NHS England perspective. We started that formally this week, and that is couplefold. Every Monday, we do a weekly clinical brief, sharing what is going on to the clinicians like us and to the operational teams out in the hospital. We assume that information is out there, but often it is not. Even this morning, we shared what flu is doing, what covid is doing and what the occupancy is doing, so that people are sighted on what is likely to come, particularly over the next couple of weeks, so that they can be prepared.
Secondly, we have a co-ordination cell, what is called a winter cell, where we are co-ordinating everything so that we can aim to only add value. Thirdly, how do we escalate people in trouble and add support, but also de-escalate so that we are not there to create noise? There is a huge amount of planning, testing and rigour that has already gone into this place.
Q34 Chair: Just as a brief follow-up to that, I suggest that you concentrate on your comms really well, so that the general population can be reassured that you are making those preparations.
Samantha Jones: Absolutely, Chair. I will just take the opportunity to encourage everybody to have their vaccinations if they have not already—families, particularly those vulnerable individuals and also children; that is really important.
Chair: Brilliant.
Mr Betts: I will declare an interest: I have had my vaccinations.
Chair: Well done.
Q35 Mr Betts: I have two questions. First of all, why is there an increase in people coming to A&E? Do you actually know?
Sir Jim Mackey: Not really, no. We have actually had quite significant growth in demand in urgent care: roughly 6% this September compared with last September, which is pretty significant when you are on fine margins. We have also had significant growth in elective demand this year, which we are struggling with. It is not quite as high, but it is similarly a problem for us.
We have looked at everything, trying to work out whether there is a geographical issue or a disease pattern issue, but it is fairly uniform and consistent around the country. We think that it is related to better access to primary care. Patients are now more able to see a GP and are reporting better experiences from that. As a result, more patients are flowing through into hospital care. But we cannot say for definite what it is.
We started the year thinking that we had had a bit of a spike—sometimes you have spikes and they settle down—but it has been pretty consistent, and I think that we should assume it is here for the foreseeable—
Q36 Mr Betts: Have you surveyed patients coming into A&E and asked them how and why they got there?
Dr Rowland: I can certainly tell you that, at a local level, we absolutely have. Sometimes, though, it is about ensuring the accuracy of that. People have a right to walk into A&E, and they might have tried other routes, but we know that referral rates from each of those are fairly standard. The majority of patients self-present to A&E, and most of them rightly believe that they need support and help.
Q37 Mr Betts: Some of my GPs have told me that they think 111 is part of the cause, because people go there and the default is always, “Go to A&E.”
Dr Rowland: I can certainly come back on some of that, looking at the increase in demand. There has been a significant spike over the summer in the use of 111, in the region of 11%. However, that has not translated into an increase in 111s going over to A&E. That has stayed at about the same level, which is around 6%. Overall, everything has increased slightly.
Sir Jim Mackey: We have looked hard at whether there has been a change in thresholds between 111 and primary care—whether there has been disproportionate growth in hospital care relative to the volume growth in primary care and 111. We are not seeing any evidence of that.
Q38 Mr Betts: One thing that has grown is the number of staff working in A&E—more than 20% across all the categories, whether nurses, doctors or senior doctors. That is higher than the increase in the number of people coming through the doors, so why is performance not improving?
Dr Rowland: It is absolutely fair to say that there has been a significant increase in resources going into the UEC—urgent and emergency care—sphere. I think that demonstrates that, over the past couple of years, there has been a significant improvement in performance, as the Report rightly draws out. However, that has plateaued. It rightly demonstrates that investment is required, but is not the only answer.
Some of that is about how the figures are captured. For example, in A&E, those staff might also be covering other areas, such as same-day emergency care, in order to increase those alternatives. Certainly, as an A&E consultant, we cover both areas. So some of that is about the other additional options. Some of it also relates to the fact that corridor care is not good-value care for patients, for staff or for resources either.
Sir Jim Mackey: Similarly, I think same-day emergency care is a big factor in this, but also, from the analysis, there has been a big shift away from agency and bank usage, which we have been trying to drive down. Some of that has involved substantive recruitment—permanent recruitment—to avoid the expensive use of agency staff. That is part of the equation.
Q39 Mr Betts: That may be a saving, then, through less use of agency staff, but the cost per patient has gone up significantly. Over the six years from 2018, the cost rose by £69 per patient, allowing for inflation. There is therefore lots more money going in and no better service at the end. That is not right, is it?
Dr Rowland: If I may come on to the cost per patient, we absolutely acknowledge that it has gone up and has then started to plateau again over the past couple of years. That does not surprise me, if I am honest, being there in A&E, and I am sure that it will not surprise Tim either. It is evidenced—and also evidenced in the Report—that the patients coming through to A&E now are much more complex. That is estimated to be an increase in complexity of about 2% to 3% per year.
The reason that is happening is that we are managing to see the lower-complexity patients in alternative environments, whether in same-day emergency care, as I said, urgent treatment centres, primary care, and so on. As a result, you see more complex patients coming through to the A&E. The evidence on that in the Report was welcome, and you will have seen the increase in diagnostics, particularly CTs and MRIs. They are quite expensive investigations, and they are investigations that take a significant period of time to deliver. Their use has really increased over the last couple of years—on average, they have both increased by about 50%—so the amount of diagnostics, the amount of time and the complexity of each patient now coming through to the emergency department has increased.
Q40 Mr Betts: But why are the people who want those complex procedures getting to the point of A&E? Why is the system not picking them up a long time before?
Dr Rowland: It depends a little bit on where they are. But absolutely; that is exactly our intention, particularly with frailty. Can we manage people in a different way? That is what neighbourhood health is here to deliver, and some of it is about changing how we have worked in emergency medicine over the last couple of years.
To give an example, a particular change has happened in what is called silver trauma—that is, trauma in the elderly population. Previously, if you had come in having had a fall from standing, and you were 80 years or plus, you probably would have had a review and some X-rays. Now, we know that was insufficient, and guidelines suggest that we treat people very differently. In what is called “silver trauma”, you now get a CT scan, which is nearly all of the body, and we have picked up several injuries in that way. We are investigating people in a much more thorough manner and picking up occult injuries that we previously would not have noticed.
Q41 Mr Betts: Is there a tendency to over-investigate in some cases?
Dr Rowland: There is no doubt. The evidence is there that we will increase investigations when, for example, there is a highlight. A previous example I have—I do not know whether anyone will have seen it—was a campaign called “Think Aorta”. When that was publicised, there was no doubt that it would be at the forefront of your mind, and you are therefore more likely to do an investigation.
Another particular example is cauda equina. We know that following the publication of HSSIB’s investigation, which I think was in 2002, the number of MRIs increased. Some of that was absolutely right, because that report was flagging that we were not picking up as many cases as we could. However, the incidence has not increased, so there is definitely now a degree of greater investigation to catch a small population of patients.
Q42 Mr Betts: So you are going to the Chancellor and saying, “Chancellor, we need more money again for the NHS.” How do you convince him that the money is going to deliver better results?
Samantha Jones: I think the important bit that the NHS England team is focusing on is the things that will make an impact for the individuals using urgent and emergency care services—whether that is avoiding admissions, how people are actually treated in the department, what happens when a decision to admit is made or how we actually support partners through primary care and social care. The important bit for us in DHSC, collectively with NHS England, is to ensure that people are doing the things that really make a difference, hence all the model documents that have been described. It is about actually doing the things that make an impact.
Q43 Mr Betts: But is there a tendency, as before, to over-diagnose, to over-treat and to try to put everything together, so there is no risk at all that the doctor can be blamed if things go wrong?
Samantha Jones: I think I will allow the doctors to answer that question, although I would be happy to have a go.
Dr Rowland: There is no doubt that, when a report suggests that further investigation or further imaging are required, that will be at the forefront of your mind. There is no doubt that things like the HSSIB report, which flagged medico-legal concerns, will then be at the forefront of your mind. However, as a medic, it is paramount that we deliver the right patients with the right investigations at the right time. We must also balance that with not doing incorrect investigations or too many investigations, as that can potentially cause harm, so it is up to the individuals. However, we support the guidelines that surround us, and some of those have changed. For example, to go back to silver trauma, that is a guideline, and our NICE guidelines have changed. The expectation is that we follow some of those, so we follow the guidelines in which we work.
Sir Jim Mackey: This is also challenged all the time, nationally and locally, in the operational environment. It is really important to keep the challenge, but also to keep the balance right. For clinicians, especially younger clinicians coming through, when they have decided to not investigate and something goes wrong, it is pretty impactful on them as well, so that adjusts behaviour. That is not to say that the growth in diagnostics has gone without any scrutiny or any oversight at all; it is being challenged, it is just very hard to get the balance right.
Q44 Mr Betts: I understand that during the junior doctors’ dispute, when they were not around in A&E and the consultants stepped in, there were fewer referrals from A&E upwards—more decisions were taken in A&E. Is that another reflection of how junior doctors without as much experience tend to pass things up into the system that a more experienced doctor probably won’t?
Dr Rowland: I can answer that—I was working during the IA, so I can certainly comment. There are probably a couple of different layers. Definitely, as consultants we are more experienced and are therefore likely to make different decisions from our junior colleagues. In some respects, we are likely to, and will, refer less, and we are likely to take more risk, based on our experience.
The second thing that I would bring to the Committee’s attention, though, is that how people worked during the IA was also quite different; an example is the process in most A&Es. If I see a patient in A&E, I call one of my colleagues, such as a medical colleague, and the patient is referred through the system. A lot of staff could be co-located within the ED, so you could easily have a conversation with a colleague who might be there because they were relieved of other duties during that day—there could actually be several other consultants—and therefore not need to refer.
Chair: We are quite behind time, so I am going to take a very short break today. We have got a lot to cover, but if you want to have a leg stretch and whatever else you want to do in four minutes, please be back here fairly promptly at 16:40.
Sitting suspended.
On resuming—
Chair: We now resume our hearing on emergency care, and Anna Dixon is starting the questioning.
Q45 Anna Dixon: I would like to come back to the issue of hospital flow, and particularly the related issues of bed occupancy and delayed discharge. First, on bed occupancy, the NAO Report notes the increase from 87% to 92%. Professor Briggs, what do you think is a safe occupancy level?
Professor Briggs: The RCEM says about 85%, and I think that is very reasonable, but the data also shows that about 14.7% of all bed days are taken up by patients who are ready to go home. Again, if you are in hospital for a long time, there is risk of harm, deconditioning, loss of mobility and so on. We have to make sure we use every bed available for the right patient.
For me, part of this whole issue of getting the flow right is making sure we have got our discharges sorted. One thing we have been trying to do, as part of the programme of bringing in the right standards, is having the ward round start on time, having ward rounds in the afternoon, identifying the patients who are likely to go home tomorrow morning and making sure their discharge summaries—their TTOs—are done. Transport is also really important; that is another really big issue. It is also about making sure that the discharge lounge, which is available now in many hospitals, has the appropriate number of patients at the right time. The more patients you can get there and through by midday, the better the flow in terms of bringing patients through from other parts. That is one of the things we are driving to make sure we use our beds efficiently and effectively.
Q46 Anna Dixon: Effectively, you are agreeing with the RCEM that 85% is the ideal occupancy. Obviously, we are a long way from that. It seems there are two solutions: either more beds, which was the direction my colleague was going in earlier, or eliminate the 4.7 million lost bed days, which is the number I have here. Obviously, it is a question of dealing with both, so how much do you think you can do through eliminating the 4.7 million to get down to 85% occupancy, and how much do you think we are short of capacity?
Professor Briggs: On the second part of the question, I do not know, but one thing we are doing at the moment is the RiO, which is working across six trusts in the midlands. We are aiming to eliminate the P0, which is the patients go home, and P1, which is they need a bit of support—the hospital-related delays. We are really trying to remove those barriers to discharge, because those are absolutely crucial. By doing that, we want to try to achieve 80% occupancy by Christmas day and then to sustain that in the first week of January.
So I think it is both parts. One thing we have to make sure of is that every bed is used for the right reason. That is why we are working with this group of trusts. We are already seeing, for instance, that the percentage of beds occupied by long-stay patients is reducing in relation to all other trusts in the midlands region, and they are improving at a greater rate. We are making progress there.
However, I understand that we have a certain bed base, and we have increasing demand. There is probably a need for more beds as well.
Q47 Anna Dixon: It sounds like quite a lot of that focuses on what is within the control of the hospital to accelerate discharge. Permanent secretary, you pre-empted my questions: how much of this is down to the lack of social care? How much is down to the lack of other intermediate or step-down care? What plans are you putting in place to ensure that there is more seamless join-up at that back door with community health services, social care and other provision?
Samantha Jones: If you are okay with it, I will ask Emma to describe how we have joined up planning and execution, particularly with our social care colleagues, from a Department perspective. About a third of delay and people waiting for discharge is for social care reasons. As you know, some of that classification is a little more difficult to drill into, but we do have a focus in terms of the intersection, which Emma will talk about. In addition, as you are aware, we have capacity information for social care from both a local perspective and a regional perspective in terms of both home care and care homes. We are matching capacity and demand at ICB level, although I would not say that the data is perfect—that would not be the right thing to say.
Finally, before I hand over to Emma, from a Department perspective, with the Secretary of State, there is regularly—weekly, if not more often—a clear focus on the reasons for delay and what is happening from a discharge perspective. We go through that weekly in terms of attendances, what is happening from flu and weather perspective, and what is happening within the hospital from a plan perspective. There is also a very clear challenge from our Ministers around working with local government and local authorities on what more can be done on that particular element.
Q48 Anna Dixon: Does that third you talked about include hospice and end-of-life services? Is that in the same third as social care, or is that in community health services?
Samantha Jones: I do not know, actually; I will confirm that.
Q49 Anna Dixon: I would also be interested in what the other two thirds are made up of.
Samantha Jones: On end-of-life care and hospices, as part of this but also as part of our work around social care reform and the national care service, we are looking particularly at end of life and what that means in practice for people. Emma, do you want to talk about our processes?
Dr Rowland: As the permanent secretary said, the Secretary of State has brought us all together, so we are all very much around the table, and we are using winter as the leverage to make that start. It is very clear that planning and winter are expected to bring all partners together across the system. Likewise, from the top all the way down to the bottom, the expectation is collaborative working. We know that when people work collaboratively we get much better outcomes, so with those board assurance statements that I mentioned earlier, the expectation is that local authorities and others will be around that table.
There are also some very specific examples, perhaps going from a national level. We have declared a focus on discharge because we know that is what is going to get us through this winter, and we have done it together. It is us standing side by side. Secondly, coming down to that next level—
Q50 Anna Dixon: Sorry, do you mean standing side by side with the LGA?
Dr Rowland: With social care.
Coming down that level, from a regional perspective, what we are doing is hosting weekly regional calls where we look at two acute and one community provider. Again, that is us coming together to say, “What are your blockers, and if everybody is around the table, how can we cut through some of those barriers and deliver?” Then, as Tim alluded to, there is much more at the local level. That includes the RiO in the midlands, but we also have what is called DAG—the discharge and admissions group—which is a combination of social care colleagues, local authorities and NHS England coming together to say, “How can we help you as a system unblock some of your barriers, and what are those barriers?” We are taking a much more collaborative approach at looking across the part.
Q51 Anna Dixon: That sounds positive in terms of working together, but the incentives are not there to collaborate, are they? Age UK suggested in its briefing on corridor care that part of the deterioration from March 2022 was that special arrangements for funding social care and discharge that were there in the pandemic came to an end. Do you think that plays a part? Are there arguments to change the incentives, whether or not we are using the better care fund, to get people out quicker?
Samantha Jones: I was just about to talk about the better care fund for precisely that reason. The incentives may may be different from a local government perspective and a health perspective, but there is the pooled budget in the form of the better care fund. At both national and local perspectives, there is a very clear expectation about what the better care fund is to be used for and how that actually works through in practice.
As part of our work to look at how we can better support social care in terms of social care reform, we are looking at what else we need to do to make sure we have the right levers, from a national and local perspective, to support the better care fund, if it is over and above, as well as how we can give the better care fund teeth locally so that all partners are playing in as part of it.
Q52 Anna Dixon: Can you remind me how much is going into better care this year?
Samantha Jones: Over £9 billion.
Q53 Anna Dixon: Okay. Because obviously at the moment we are spending money on failure, aren’t we, with £2.7 billion estimated costs of delayed discharge? We have heard a few of the steps that you have taken to try to reduce that spend and the cost of failure around the third that may be connected with social care, but are there any other big blocks in the other two thirds and how are you addressing those?
Dr Rowland: One of the important ones is hospital discharge. There are different ways that you can cut up some of this data. One of the simplest things that we have said is that at least 22% to 23% is within the capability of the hospital, what is called P0—pathway zero. That means no immediate changes to care, just pure process. That for us is a massive focus.
A large number of patients go through there. Delays are relatively low, but at cumulatively that starts to add up. It is about 9,000 patients with a three-day delay on average. The question is how we reduce that. That comes back to what Professor Briggs said about making sure the board runs, making the decision, making sure the paperwork is done on time, making sure the logistics are all done and the transport is ready and booked—that is what we need to get a grip on, certainly from a hospital perspective.
Q54 Anna Dixon: Coming back to you then, Professor Briggs, work on flow is not new. I was reminding myself about the Health Foundation’s work on flow in 2013. There are things like discharge planning starting on admission. There have been innovative models and conflicts of interest around Helpforce and the use of volunteers to try to speed up discharge, whether that is running around to the pharmacy or making sure everything is in place. There are lots of good practice examples, so why are we having to do this all over again and come up with a special program? Do leaders in the NHS just forget what works?
Professor Briggs: Covid has, without a shadow of a doubt, had a big effect on the health service. Some of the learning has been lost, both on the operational side and clinically. The great thing we have with the GIRFT program is that people respect it, and we have the right clinical leaders who we can go back out there now, redo that and relearn it. The key will be to embed it.
That is what Emma and I are really trying to do—to make sure that it sticks and we actually get flow and the discharges right. We now have a programme, working together, so that we can make this work this time. It is really important that it does. That is where we are. As we go forward in winter, with the 40 trusts we will be working with, we hope that we will see significant progress.
Samantha Jones: Just to add, as Jim has talked in the Committee before, this is about muscle memory, setting expectations and NHS England holding every single leader within the NHS to account—saying, “This is the national standard and this is what is required.
Q55 Anna Dixon: You must have déjà vu, like me, Sir Jim.
Sir Jim Mackey: Absolutely. I was going to say that there is not many of us in the room, probably, who remember the 2013 Health Foundation thing. We are putting a lot of emphasis on rebuilding capability and curiosity in the board, and the hunger to try to find a place that has done it better and made improvements, whether the evidence is here or abroad.
Emma and I had an email interaction over the weekend about how, whether we like it or not, a large part of our workforce has only worked in this kind of context. They have not worked in a four-hour world necessarily. They have not worked in a world where it has been anything other than a slog to find beds for patients. I remember what it was like. I remember how lovely hospitals were when they were free-flowing and EDs were empty, but that is not an experience that a lot of our staff have ever had.
Just as a check on the problem with macro stats versus local stats, we often default to the discharge thing being a social care problem. That was never really my experience as a hospital leader. In the north-east, generally, our council partners were brilliant, whereas in other parts of the NHS social care is a really big part of the problem. We must have a nuance between our overall, national approach and reflecting the local differences and variation; otherwise, we will solve the wrong problem.
Q56 Anna Dixon: I have one final question, about data and technology; I will start with you, Sir Jim, but if anyone else wants to come in, please feel free. I went to visit the Bradford royal infirmary, which has an amazing centre—I guess it is a bit like air traffic control—with data screens showing who is coming into A&E, all the flow through the hospital and who is being discharged. As demand was coming in through A&E, staff could send people to say, “These are ready to discharge. Can we accelerate them going out?” It was very calm in there, actually. Gone were the days of screaming down the phone, “Have we got a bed? Have we got a bed?” It was all very calm and wonderful. The results are not too bad: the Bradford royal infirmary has 83% A&E four-hour performance—it is not the worst. That model had real-time data in, effectively, a control centre for the hospital. I have no idea how widespread that is; it looked brilliant. How much can that tech and data help to get down those delayed discharges?
Sir Jim Mackey: It is not the only thing. In my Northumbria experience, at that time the trust was quite poorly developed from a technology point of view—although it did have bed management technology, which was hugely valuable. Bradford is generally one of the top 10 performers in the weekly ED stats, so it is actually doing pretty well overall.
Anna Dixon: Please come and visit if you have not recently; it is great.
Sir Jim Mackey: Absolutely. The command centre is really impressive when you see it. Lots of people are trying to replicate that—they have an EPR instance that is similar to it, and can replicate a lot of it—and others are using adapted approaches, but if you do not have live data on your bed occupancy, who is ready to go and all those things, you are going to really struggle, so that absolutely has to be part of the plan.
Without the leadership will, without clinical and operational alignment, and without the whole system being in sync with itself, that technology is not going to get you there either. I have seen a bit of that: there have been times where people have put the technology in and thought that that would solve it, but if you do not have a good relationship with social care, or if primary care is out of balance, you are still going to suffer.
Q57 Anna Dixon: Bradford also has a brilliant ED model with a local hospice. It is called REACT. That is why I asked about hospice: they turn people around at ED who do not need to be there.
Sir Jim Mackey: It does very well. Historically, at different times, that team have had challenges, so they have done a fantastic job there.
Q58 Tristan Osborne: Many of my questions have been answered, but I will focus on a couple of areas. I represent Medway and Kent. The Kent and Medway ICB has challenges, as does Medway Maritime hospital. In my area, the over-65 population has grown by 25% in 10 years. We know that those people are much more likely to go into hospitals. The bed population has not grown in a similar way and the care home capacity in the local community has not either, so the hospital struggles. I know that you have alluded to this, but have we modelled which parts of the country have process problems—potentially those are in the north-east—and how many problems are related to specific care problems in those localities? Have you modelled what the main challenges are in each part of the country?
Sir Jim Mackey: We have not modelled everywhere, but when there is a cause for concern—Emma will come in on this—we have an approach called tiering, in which we look at an organisation and a system. The first step is diagnostic: what is going on here? Where do we think this system is out of balance? Can we bring in data and insights, then connect to somewhere else in the country that has a similar problem but has been able to solve it? It is not a one-size-fits-all thing at all; it has to be quite tailored. The system you described has historical, complex challenges that are multi-factorial. It is one of the handful of our most worrying places in terms of all the problems it has to solve. I can assure you that it is very tailored. There is a lot of data analysis that goes in initially to try and work out exactly what is going on and then try to help with targeted support and intervention.
Dr Rowland: We look at specifics because everyone is not the same. Every population is not the same, and everyone’s needs are not the same, just as every A&E is different. We try and do two things: we ask what we can take from a model and what needs to be completely nuanced. We try and balance that. Certainly, when it comes to specific support, it very much depends on population needs, primary care, the community care around it, social care and the whole package.
Q59 Tristan Osborne: We have a new CEO for the Kent and Medway ICB and he is outstanding. There is a clear plan going forward, which I am impressed with. There is change coming, and I think there is confidence in the ecosystem about that.
My question is around the fact that—as you rightly said, Sir Jim—in parts of the country the care system, which represents a third of the discharges, is extremely expensive and has also seen a reduction in the number of beds. Is there any nuance around perhaps supporting some ICBs to expand some of that community capacity? We have an ostensibly privatised care model in our area; it is extremely expensive for the council, and councils are struggling financially. Is there dialogue with MHCLG and others around how we build that capacity?
Secondly, there is a proposal by the NHS to move more into neighbourhood at the moment. Obviously, a lot of people entering primary are in hospitals, which are secondary care. There is a concern that, as you take money out of hospitals and move it into neighbourhoods, they will not have the capacity to deal with those challenges. Has that been fully gone through?
Sir Jim Mackey: I will take the second question and dodge the social care and MHCLG one, so as to leave it for Samantha.
The neighbourhoods thing is one of our core priorities. We absolutely need to be shifting people who are in hospital and instead care for them more locally, wherever possible. That is what the whole philosophy is about. That should also be done in a way that is value for money. There is a huge tension every day about whether we just take a lot of money out of the hospital sector and invest in that and then hope that it stems the flow. We have done that before during my career. It has not worked and we have ended up with double running.
Alternatively, can we stimulate things with financial mechanisms? In the next couple of weeks, we will meet a group of GPs who want to take more risk in out-patients, for example, where they think that they can shift out the out-patient model. That would then free up resource to allow them to start investing in other things. However, importantly, it also reduces the burden of work in the hospital sector. I just left a discussion about this earlier. I get played back to me a lot, “What do we do with the stranded costs in the hospital sector when people have lost income because they have lost work?” I honestly think that that would be a lovely problem to have, because every hospital in the country is just absolutely full to the gunnels.
So I would like us to take a bit of risk on shifting patterns and trying to get the financial incentives right so that we incentivise and encourage primary care and other partners to do that, and then get ready and agile to deal with the fixed costs. However, I think that, realistically, that is a few days down the path.
Samantha Jones: In answer to the first part of your question: yes, would be the summary. It links through to the Casey commission and the question of what the future of the national care service looks like in practice. Obviously, we do not just want to wait for that, although it has now been brought forward. As part of our winter planning, we definitely work very closely with the other Government Departments; in fact, they are part of the winter team. In terms of what we do locally to understand capacity, there is a piece of work that we are looking at with Ministers at the moment around social care reform for workforce and what that looks like from a capacity perspective and in terms of supporting our social care workforce. It also looks at the future of the funding around the care home sector.
Q60 Tristan Osborne: I have a final question, as I am conscious of time. Are there any data gaps here? Is there anywhere where we need to be much more cognisant of data or where we have data weaknesses? Some of your answers have alluded to the fact that you might need to improve some of the data collection, or that the data collection needs to be better standardised. For instance, you mentioned the question of how we define bed blocking. Is there a national definition of that that every hospital is working to? If there is not, how do we know that the data is really salient? Lastly, on this seven-day service, the issue could be, “How do we get hospitals into a seven-day service process?” Obviously, they have the staffing, and the capacity, potentially, in terms of the buildings, but how do we get the operational elements to get to that point, so that we can have more efficiency with the structures we already have? There are two questions there, actually.
Sir Jim Mackey: I will start, and then others can correct me when I get too far in. On discharge delays, there is a bit of subjectivity and blurriness at times, in my opinion, when it would be really nice to be definitive. Some of that is our data, but sometimes it is just complicated patients, where it is hard to tell, “Is this a social care problem or a health problem? They need something.” We need to get better at tightening that data up.
I would also love a scenario—I think this is referenced in the Report—where, at every stage of the pathway, we are clear about how long that stage should take and whether we are actually complying with that. We are nowhere near being able to do that, in terms of not just setting the standards but having the technology that could work in real time. No one in the world is able to do that yet, but I would have thought that, within the next few years, that would be possible and within reach. So we are working with the data that we have and we are trying to refine it as much as we can, but there will always be a bit of blurriness in it.
Samantha Jones: To go back to the earlier question about patient experience, from a patient or family perspective, they just expect us to know, across health and social care and within the hospital, what is actually going on. It is not a very good answer for any of us to say to any family member, “Well, actually, it is because of this.” There is always a need to make sure that we have the most joined-up data possible and that everybody agrees on the data, so that you get past the arguments about, “Well, actually, it’s not a social care delay; it’s this delay.” We do have the data on those patients with no criteria to reside, which is a terrible expression. That breaks down where the delays are in practice, but that can always be refined.
Q61 Tristan Osborne: Lastly, are the definitions of bed blocking and corridor care standardised across all hospitals? Are they interpreted in exactly the same way from one trust to another?
Dr Rowland: There are two things in there. With regards to corridor care, there is a clear definition that is available to all. There is naturally some local interpretation of that, and we know that that is happening. Certainly, that is a conversation that goes on particularly among clinical and operational bodies.
For what you define as bed blocking, there is no definition as such. However, as the team have explained, what we have got recently is a new acute discharge situation report, which defines what the patient requires. From the point at which you are ready for discharge, what do you now need? It is what is called pathway-based, so it is needs-based. It is not perfect, but it gives us an idea of how many patients might not have any additional care needs to go home, on pathway 0, all the way to the opposite end of pathway 3, where they might need a care home. That gives us an idea of where we would be best to focus when looking at those delays and the beds that are potentially lost during that time.
Sir Jim Mackey: Just to add, on this discharge thing, I cannot overemphasise the need for all partners to work together. There is nothing worse than being a family member on the end of it, with it sounding like health and social care are arguing about whose problem it is. That needs to be as joined up as it can be, and the best places really deal with that properly.
Going back to the crowding points earlier, I would love us to have a crowding metric. We have talked to the RCEM about that, to see whether we can construct something together. I think that that would be really useful for us in trying to make improvements in this area as well.
Samantha Jones: Another point I was going to make is that it is pathway-based; we do not use the expression “bed blockers”—
Tristan Osborne: Apologies; I know that you don’t.
Samantha Jones: No, absolutely. That is because, as you were saying yourself, it is an individual within that bed, and that expression makes them feel as though they are in the wrong place. It was the definition previously but, as Emma said, it is about understanding the pathway delays, because, as Jim said right at the beginning, it is about the dignity of the individuals involved as well.
Sir Jim Mackey: The corridor care metric was started from scratch, with the coalition as well. Tim, Emma and I have all been to a hospital—which I will not name—that was an outlier and had terrible, visible examples of patients on corridors. When I went to see that hospital again, there were no patients on corridors, but the data still looked bad because the definition had started capturing things elsewhere in the hospital that people were less focused on. I am sure that, over time, we will refine the measurement and get more consistency, but we just needed to make a start, try to take a stand and start shining a light on it.
Professor Briggs: Can I also say something about the seven-day hospital? One of the conversations we are having is because discharges fall off at the weekend. What will be absolutely critical this winter is that we maintain discharges on a Saturday and Sunday, because otherwise trusts are blocked up by the Monday, and do not free up until the Tuesday or Wednesday. We have got to change that.
Conversations are ongoing about making sure that the discharge lounge is open at the weekend and that we get the ward rounds—again, the board rounds—done at the weekends. In that way, we ensure that it becomes a seven-day hospital, and we absolutely maintain our discharges during the weekend, which means that, on the Monday, you start afresh and you can really start to get the flow right.
Tristan Osborne: I look forward to seeing those results. Thank you.
Q62 Chair: On that point, Professor Tim, in anything I have ever had to do with hospitals, they have always made a special effort to get people out before Christmas. Why are they not doing the same thing to get people out on a Friday, before the weekend?
Professor Briggs: That is part of the conversations that Emma and I are having with individual trusts, systems and what have you. Again, I think it is part of the relearning. I think we have to make it business as usual, which it has not been. However, I think people are now beginning to understand the need for this.
Discharge lounges being open at weekends is going to be critical; what they must not do is get bedded by patients that come in the night before. If we can get that right, get the clinicians and the teams coming in to do the ward rounds and also get discharging by nurse-led discharge and criteria-led discharge, that can make a big difference.
Q63 Matt Turmaine: I would like to talk about the delivery plans, and it would be great if I could direct my question to you, Sir Jim. The NAO Report says, “The main objective of the two-year 2023 plan was to deal with reduced patient flow through hospitals resulting from increased bed occupancy rates, which NHSE saw as the ‘key driver’ of falling A&E performance. The 2023 plan was to increase capacity in A&E, as well as expanding care people can access without going to hospital, such as community care.” What changes have you made under the newer 2025 plan in response to the slightly limited improvements made in the 2023 plan?
Sir Jim Mackey: As we described earlier, especially with the new ministerial team, there has been much more focus on improvements in the round, rather than on trying to over-focus on one specific element, especially on the social care element interface with neighbourhoods and primary care. In the next couple of weeks, we hope to publish a new urgent and elective care strategy, which will set out a bit of a path, also for the next few years, in terms of strategic direction.
The 2023 plan was before my time in this role, but from memory the team were very focused on long ambulance waits as well. Actually, to be fair, they made a pretty significant improvement in category 2 performance. We sustained that through last winter. So it was as stated in the plan, but after the plan was published there was a really big focus on category 2 performance and handover delays, which did improve fairly dramatically.
What we are now doing is trying to take a more rounded approach and a more tailored approach, as we discussed before, and making sure that, in particular organisations and systems, we are focused on what the issue is, rather than having a standard approach that works everywhere.
Q64 Matt Turmaine: My understanding is that the 2025 plan is for a similar period. Do you think that this plan is going to be more effective? I absolutely acknowledge that the 2023 plan did deliver a lot of what it was supposed to do.
Sir Jim Mackey: I would hope so. As I have described before, we are trying to deal with an awful lot. When you look at it and you sit back from all this, I think that what local leaders are trying to deal with is often understated: the level of complexity, the financial turnaround that they are trying to pull off, the improvement of standards across elective and urgent care—the big shifts. There is an awful lot that we are trying to do at the same time, compared to other times in NHS history. We are trying to improve at a rate that is much quicker than ever before, and in a much tighter fiscal context—the economy is much tighter than it was the last time we made big improvements. We are all cognisant of that and just trying to keep the right pace and keep things as stretching as we can, but not so that it feels unreasonable and therefore unachievable.
Q65 Matt Turmaine: The 2025 plan has more focus on “operational improvements” in A&E. Emma, is there anything that you want to say on that, which I think is your area, isn’t it?
Dr Rowland: Yes, absolutely. I also used to be the chief operating officer at Homerton, so it probably crosses both.
That stems all the way from that grip and control, which we have hopefully alluded to. Yes, it is about resource and mapping out the pathway, but it is also about getting hold of your data, and understanding what your flow and your patterns look like and what that means. That is all the way down from the executive and the board to the individuals on the ground. Some of that hopefully comes by the models that we have alluded to.
Again, the expectation is to comply or achieve by other means. With model ED, for example, it is there and has come from the learning, so how are you implementing it if you are not achieving? Likewise, again through the grip and control that we have alluded to, across the next 72 hours, what does the board round look like, the expectation for you to discharge the patients, and so on? Then, how do we finish off towards the end with that collaborative working across the patch?
Q66 Matt Turmaine: So, as a result of that different approach, you do not envisage us being here in a couple of years’ time talking about the same issue—or is there a risk that that might be the case?
Sir Jim Mackey: Emma is still young enough to be here, so schedule her in.
Matt Turmaine: Time sometimes moves slower than we think with these things, doesn’t it?
Samantha Jones: We are working on the basis that this plan will work. There is always a risk with any plan, of course, but there is total focus on delivering this plan and the areas that have been set out.
Q67 Chair: Before I bring Anna in, I want to ask about something that is not covered at all in the NAO Report but occurred to me when I was reading it. How far has industrial action by junior doctors affected the performance of these two plans?
Sir Jim Mackey: That is a really good point. We are potentially going into another industrial action soon with consultants, which is terribly difficult to manage, as everybody will be aware.
When you look back at last year, it is easy to forget that we had a lot of rounds of industrial action with resident doctors. In the event, as colleagues have pointed out, performance improved in the short term, but over the longer period you pay the price; you get deteriorated performance afterwards as things start to settle down and everyone starts to get back into balance and so on. It is hugely disruptive from a performance point of view—no question about that.
The biggest issue, though, is that it squeezes headroom—leadership and clinical headroom—for innovation. Everybody you meet will want to do all the things we have highlighted and talked about today. You very rarely meet anybody who is arguing about whether patients could be in a different setting, whether we could improve discharge or whether we could be more seven-days. It is just really hard to do when you have a strike every few weeks.
There is the headroom impact: do people have the time and headspace to do it? There is also the financial impact and the actual performance impact: the short-term gain for longer-term deterioration over time. You weigh all those things up and it is very hard to improve when you have industrial action.
Chair: Thank you for that candid answer.
Q68 Anna Dixon: I want to come back to the issue of mental health. The data suggests that about 3% of ED attendances are mental health related, yet they are twice as likely as other patients to remain in the department for more than 12 hours. What action are you taking to address long waits for patients who are in mental health crisis and ensure that they are getting the right care in the right place?
Sir Jim Mackey: I will bring Emma in in a second, but you are right, Anna. Especially when you look at very long waits, a very big proportion of those patients are mental health patients. It is the wrong place for them—it is not the right environment for them—and it is hugely disruptive for other patients and staff, so it is part of our approach. There will be new mental health strategy published at some point, as well. Emma, do you want to pick this up?
Dr Rowland: Certainly. Mental health patients are obviously very vulnerable, and they have an extended stay in A&E, as you rightly pointed out. I suspect that a significant proportion of patients in those 24 hours are probably mental health patients.
It goes all the way through the path, really. We have invested in how we can prevent those patients escalating to this need so that they do not require A&E, because A&E is the last place anybody should end up. What does that look like? Things like crisis cafés and community healthcare in primary care. How do we make sure that people are as well as possible all the way through?
How do we ensure that we have the collaborative pathways right when people are heading towards A&E—for example, mental health in A&E? We also have mental health lines on 111 and that also works with 999. How do we make sure that that individual goes to the right and the safest place that they can do?
Once they are in A&E, care and safety is obviously paramount. How do we look after that individual, and how do we make sure that they get the needs they want? Most A&Es now have a psychiatric liaison service—a direct 24/7 service that they can lean into on mental health—so that individuals get prompt reviews. The expectation is that that is a synchronous review; you do not wait for one person followed by the other person.
Q69 Anna Dixon: Are they usually people employed by the mental health trust who are co-located in the ED?
Dr Rowland: Yes.
Q70 Anna Dixon: And does it count as a place of safety? Is it set up to meet standards to allow people to be effectively safely detained?
Dr Rowland: There are variations in standards. A&E, by definition—in most A&Es—is declared a place of safety. That is not necessarily the same thing as saying that we have a safe environment for an individual. A noisy A&E is far from ideal for a poor patient who is acutely disturbed during that time.
We are very much trying to ask what a mental health A&E looks like, and what other things look like, so that we can get those individuals to the right place. A lot of the delays for these individuals are due to the complexity of their needs, as well as the mental health beds that are required and some of the process that is required, particularly for a section 2.
Q71 Anna Dixon: Is it difficulty in accessing a mental health in-patient bed, or is it the time that it takes to assess and potentially detain?
Dr Rowland: In my personal opinion, the significant delay is usually around a bed, but there are also delays around the process for those individuals.
Q72 Anna Dixon: It would be good to get the data on that if possible. Obviously, I respect your personal opinion, but it would be good to get that.
On a different topic, we heard in evidence about some other units, and I think you talked about some of them. You used some acronyms that seem to be widely used, but I do not know what they stand for—SSTUCs or something. Those are sometimes called off-the-clock units. How much are they really the best place for people and how much are they being used to game the system and get people out of A&E?
Dr Rowland: I will try to split out all the different acronyms, because it sounds like they have all been merged into one. There are very specific units, such as urgent treatment centres. That is an on-the-clock area where you might see more minor illnesses and injuries, and it is part of what we call the left shift from A&E, so how you take some of the lower acuity patients out of A&E to reduce crowding. They are very much on the clock and the performance rate is high: at least 96% of people are seen within the four hours.
There is then what is called same-day emergency care. That is almost the other end, if you like. In A&E, if I was thinking of admitting a patient, I might see if they could instead be seen in the same-day emergency care, where their care might be co-ordinated much faster, including at consultant level, so they get the consultant’s review and the diagnostics. It is a case of trying to save a bed day if the individual is capable of doing so in an ambulatory fashion. That has been quite a change over the last couple of years. One example might be a kidney infection. Previously, you might have come to hospital for three or four days for IV antibiotics; now, you might get that, if you can walk and go home safely, through a same-day emergency care system.
There is then a new area in model ED called EEMAC—extended emergency medicine ambulatory care—which is specifically to remain under A&E. Perhaps, if I had seen a patient and I wanted an additional blood test that I thought they could go home with, they might remain in the footprint of emergency care during that time. There are three different types of settings.
Q73 Anna Dixon: And that third one is on the clock. It is still a type of emergency medicine; they have not been formally admitted.
Dr Rowland: It is not a formal admission. It comes off the clock with regards to after four hours. However, you remain on the clock with the expectation that you will be seen and treated with a total time of 12 hours. That was done intentionally, so that it should not be gamed.
Sir Jim Mackey: We are just about to refresh some guidance for the service to make sure that everybody is counting in the appropriate way. There is a bit of confusion because of all these extra services that have been developed over recent years. I have seen both ways: I have seen places that have patients off the clock when they maybe should be on the clock, and vice versa. Emma’s team are working on something I want to get out in the next couple of weeks that just says, “Can everyone just comply with these standards?”
Q74 Anna Dixon: Innovation is great, as long as it is for the right reason: getting people safe care in the right place. Whether it is on or off the clock, in a way the main thing is that people are doing the right thing and being driven not by the target, but by safety and quality. Can you give assurance that this proliferation of different models and different units is still achieving that goal of safe, timely care for patients?
Dr Rowland: That is absolutely our intention. Certainly from my first-hand knowledge—and, I am sure, Tim’s—that is exactly the intention of the clinicians and what is being driven.
Q75 Anna Dixon: And that is the guidance that you are issuing in terms of best practice.
Dr Rowland: Yes.
Chair: Well done, Anna—good line of questioning.
Q76 Mr Betts: I have two follow-ups. We have talked quite a bit about the need to have a whole-system, end-to-end approach in hospitals to the challenge of A&E, among other things. Anna Dixon commented on the system in Bradford, where there is a control position where the management of the hospital can see where everyone is and what the delays and obstacles are and look at every patient. Many trusts do not have that. Why?
Sir Jim Mackey: Because they do not have the technology infrastructure. We are going through a process of everybody installing an electronic patient record, one of the core fundamentals that allows this to start being built out. As I understand it, the system in Bradford involved quite a significant investment. Not everywhere can afford to do that and we cannot afford to do it everywhere nationally. In an ideal world, you would not just have the hospital data and all that; you would have what is going on in primary care and the social care system as well. I honestly think that over the next five years, and definitely the next 10, this will be built out—it will be everywhere; it will just happen organically—but we do not have the resource and the technology fundamentals in every place to be able to do exactly what was described in Bradford.
Q77 Mr Betts: It just seems to me so obvious that if you are going to control patient flows through a hospital, you have to know where the patients are.
Sir Jim Mackey: Everybody will do it, but they will have different degrees of technology. What Anna described is very polished. From memory, it has been there five or six years now.
Anna Dixon: They literally tag every bed and every patient.
Sir Jim Mackey: Yes. It is well established and way ahead of nearly everybody else in the NHS because they made some early moves when they put an EPR in. Again, from memory, there was some technology investment from the technology companies to try to prove the case, but that is not the case everywhere. As you have heard, we are trying to get everybody up to a basic level of technology capability, which is going to take time.
Q78 Mr Betts: Should there not be a central drive to do that?
Sir Jim Mackey: There is, but I would guess that it would cost maybe £4 million or £5 million to do that in a normal hospital. We could not do that everywhere. Even if we had the money, we have to bear in mind what everybody else is trying to cope with—all the things that people are trying to deliver at the same time. There is a limit to what people can absorb.
Q79 Mr Betts: It just seems that without it, it is harder. I am just thinking about some of the improvements.
Sir Jim Mackey: It is harder, but there are simple bed management systems around that are really effective, and people are using them really effectively to manage flow, with good performance. So it is ideal and it definitely would enhance your ability, especially if you could do it across the whole system, but we are not completely reliant upon it.
Q80 Mr Betts: Do all hospitals have a management system in place?
Sir Jim Mackey: Everywhere has a version. It means different things to different people. As I have said before, I have lived in an environment, in Northumbria, that did not have a big mainstream EPR but had a brilliant bed management system. I went to Newcastle hospitals, which had a very well-known EPR but did not have a digital bed management system. It was very old-school in the way it was developed. The EPR could not cope with the bed management system being attached to it. Because our infrastructure has been built over time and everybody has a different inheritance, it is very complicated.
Q81 Mr Betts: But it is a big problem that needs addressing.
Sir Jim Mackey: Yes.
Q82 Mr Betts: My last question is about the join-up across the piece—perhaps either the permanent secretary or yourself, Sir Jim, could answer. It is about trying to get local leaders generally together to address the issues right across the health service, social care and public health. You will have heard my past comments about ICBs withdrawing from that process and the importance of having named officials in the NHS who can link with their named counterparts in social services and public health. In the past, that has worked really well in Sheffield, but it has now been pulled apart. Could it be addressed properly, across the piece?
Sir Jim Mackey: Absolutely. As Emma has described, all our local winter planning processes should be whole system; obviously, we start in the NHS, but locally, you expect all partners to work together. We are really clear that no single organisation can deal with everything we are talking about—for example, around neighbourhoods, our work in frailty and so on—by itself. We discussed this before, and when your ICB change happened, your strong view was that there was a loss of focus in place. Last week, in a conversation about our operating, the Secretary of State was very clear with us that arrangements at place, however they are developed and delivered, for partners to work together—mainly Health and Social Care working with other partners—has to be a core priority. We are carrying that forward in what we are doing.
Q83 Mr Betts: It is all right for you or the permanent secretary to call it a core priority, but what about when ICBs do not have any regard for it and pull all their staff into the bureaucratic centre? I understand that that has been happening elsewhere as well.
Sir Jim Mackey: As we have discussed before, not everywhere has done what you have experienced from your ICB, Clive. Others would speak strongly about the place-based and partnership working. We will have a separate conversation about your ICB.
Q84 Mr Betts: Okay. I hope that that separate conversation can happen, because in the meantime, things are deteriorating. I do not know about experiences elsewhere—
Sir Jim Mackey: I checked a couple of weeks ago and was assured that in your neck of the woods, colleagues locally had seen improvements in these things. Let us talk about it offline. I will get back to being involved in that.
Q85 Mr Betts: Professor Briggs, what is happening across the country? You go around and look from a more detached perspective at how things are working.
Professor Briggs: Based on the areas I have been to, the response from many ICBs is very positive. Clearly, they have to look at the evidence and what have you. We want the local evidence, and then the national evidence. That will tell a very compelling story.
Chair: The clock is moving; it is pretty late. We can have three or four quickfire—I really mean quickfire—questions.
Rupert Lowe: I have one, Geoffrey.
Chair: Very quickly.
Q86 Rupert Lowe: Having listened to the debate, I have a question. The NAO found that NHS England has no means to enforce recommendations on diverse NHS trusts—that is one of the points that it made. I have listened to this useful debate, and my question is, when an NHS trust does not follow your recommendations and falls short on your guidelines on the number of hours people have to wait—say, 24 hours—what do you do? What is the censure on that trust and its leadership?
Sir Jim Mackey: We have powers of enforcement and intervention in extremis. From a regulatory perspective, that act has to proportionate, and it has to be a series of actions that a reasonable organisation would carry out if able. A lot of things we have talked about are changes to clinical or operational systems. In this context, if a regulatory body intervenes with or directs them, there is a significant chance that you create more risk than you resolve, so we have to exercise those powers very carefully.
Q87 Rupert Lowe: Have you ever used them?
Sir Jim Mackey: We are in the process of using them somewhere in England on another matter, so these things do happen. Generally, our intervention will involve the removal of key individuals or a board, implanting a turnaround director, and so on. These powers are used. There is a process to go through and you have to have the legal instruments in place, but as I say, as of today, a set of actions were initiated last week to enforce some clinical change where we did not have confidence that the local leadership were doing that of their own volition.
Q88 Rupert Lowe: It just struck me that it is difficult for you guys to sort it out if you do not have the power of censure over the people who are failing to deliver.
Sir Jim Mackey: It cannot be the first tool you get out of the box. In this area, everything we do is about managing risk. Everything that local leaders do is about managing risk. A real chance is that we increase risk by not knowing the local nuances and operational and clinical systems well enough. Another point here is that our whole model only works if boards do their job. We really need to build board capability and capacity over time, because in all these things, a natural inclination from our point of view is that we have to solve every problem nationally, but it cannot work like that. Everything has to be solved locally, with a few things resolved nationally, thus we create the frameworks, rules and mechanisms to support that.
Professor Briggs: From the clinical viewpoint on the local aspect, this is where the chief medical officers are really important. Since we started this whole programme, we have seen trusts build a dashboard where they can monitor in real time whether patients are being seen at the right time, and the reasons why that does not happen. Then the conversation with the chief medical officer is about why that has happened and how we prevent it happening again. I think that that will be quite effective. It was something that was missing before, but now I think—I hope—it is going to make quite a difference.
Q89 Chair: Rupert, thank you for asking that question. I do not want to get anyone into trouble, but that was exactly the same question I was going to ask about my own trust. I visited one of my local hospitals—I am not going to name it—in the early summer, and it admittedly had some capacity, but it had a delayed discharge patient who had been in that hospital for 120 days. I checked that—I did not believe I had heard it correctly. I see that my trust is at the lower end for our target, at 63%. It does seem to me that someone needs to pay some attention somewhere.
Sir Jim Mackey: Yes, we will do.
Q90 Chair: Thank you. While you are on your feet metaphorically, Jim, you will recall that in our earlier hearing on hospital building programmes, we had some discussion about the number of beds. Given the evidence we have in this Report from the NAO—that another 9,000 to 14,000 beds would make a huge difference to this whole matter—have you altered the policy, or do you have a different one on new hospitals and the number of beds that they are going to provide?
Sir Jim Mackey: We do not have a new policy on it, but in various board sessions over the summer, especially relating to the new urgent and elective care strategy, there has been a big focus on that strategy and its impact, and then the read-across into the hospital estate and what that might mean in terms of capital investment, and similarly in our work on neighbourhoods, to make sure that the modelling and assumptions in all that are consistent.
Across the board, we have a core set of assumptions, and all that is held by Paul Dinkin, our strategy director, to make sure that all those things are in sync, and we are not saying that this is going to shrink over there, when it is actually going to grow over there. There is quite a lot of realignment to do in all that. My main worry about that is that we get too carried away about how much change we are going to pull off, so we start making heroic assumptions that turn out not to be possible, because we have done that a lot over the past 20 or 30 years. Again, we are going to be as stretching as possible, but realistic and reasonable.
Q91 Chair: Is that policy aligned with areas that have large growths in population?
Sir Jim Mackey: Yes, it will be. Again, we would expect locally those plans to be sensitised. We will publish a strategy nationally, but those things need to be very sensitive to local demographics and so on.
Q92 Chair: Thank you very much for that answer. Professor Briggs, a last question to you: you are leading the Getting It Right First Time programme. What effect is that having? Is it having a beneficial effect? Perhaps you can combine that answer with how effective virtual wards are in solving the problem.
Sir Jim Mackey: He wants a quick answer as well, Tim!
Professor Briggs: I would say yes. I think that Getting It Right First Time is respected by all clinicians, operational teams and all the regions, and to the advice that we give, people listen. The great thing about it is that we look at the data and then we offer support and help.
Virtual wards have a role in helping us with discharge, or to step up or down from primary care, or indeed secondary care. Again, this is where technologies come in. Technologies for remote monitoring can make a big difference, but I think it has to be all things together, such as virtual wards, hot clinics and discharge planning. All those together mean that we will get our flow right and we will have, hopefully, a better winter.
Q93 Chair: In all my experience with hospitals, a problem in delayed discharge relates to relatives being able to take their relatives out of hospital on time. What are you doing to address that? Can you give them more notice, for example, when their relatives are likely to be discharged?
Professor Briggs: I will hand over to Emma on that.
Dr Rowland: Thank you. I do not know specific answers to that, but the expectation is that good communication throughout is obviously absolutely paramount, not only with relatives and patients knowing what is going on, but with our partners in social care, for example. To come back to the original point, I think we need to start planning discharge, including those conversations with patients, relatives and partners, right at the beginning of the journey. They should be completely involved as they go through, so that it is joint decision making.
Q94 Chair: Thank you. Permanent Secretary, do you want to add something?
Samantha Jones: This pains me, but the reason that GIRFT works so well is that it is clinically led. If you take what Emma and Tim do, it is clinically led with data—this relentless focus on the clinical leadership and the associated data. The Secretary of State is very clear with us about the importance of clinical leadership. It does not even need to be said, but it is the importance of clinical leadership leading the change that you see set out today as examples.
Chair: Thank you for that clarification. This is a huge subject that I have no doubt we will want to return to. There is lots to be done. We will look very carefully at your evidence and produce a Report with recommendations, which I hope you will seriously consider. An uncorrected version of the transcript will be available in the coming days. You are all very busy people, so we appreciate your appearance here this afternoon and the evidence you have given us, which has been very interesting. Thank you.